S. Miller

发表

Rapid pathogen-specific phenotypic antibiotic susceptibility testing using digital LAMP quantification in clinical samples

R. Ismagilov, R. Humphries, Nathan G. Schoepp, 2017, Science Translational Medicine.

Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae

R. Humphries, Shelley A. Miller, S. Miller, 2016, Expert review of anti-infective therapy.

Comparison of the AmpliVue, BD Max System, and illumigene Molecular Assays for Detection of Group B Streptococcus in Antenatal Screening Specimens

R. Humphries, Shelley A. Miller, E. Deák, 2015, Journal of Clinical Microbiology.

Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis

K. Carroll, Robin Patel, B. Ford, 2018 .

A screen of Crohn’s disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells

F. Bushman, C. Huttenhower, H. Vlamakis, 2018, Mucosal Immunology.

Phenotypic and Molecular Characteristics of Carbapenem-Resistant Enterobacteriaceae in a Health Care System in Los Angeles, California, from 2011 to 2013

R. Humphries, J. Hindler, D. Uslan, 2014, Journal of Clinical Microbiology.

First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate

R. Humphries, J. Hindler, P. Hemarajata, 2015, Antimicrobial Agents and Chemotherapy.

Activity of Ceftolozane-Tazobactam and Ceftazidime-Avibactam against Beta-Lactam-Resistant Pseudomonas aeruginosa Isolates

R. Humphries, J. Hindler, Shelley A. Miller, 2017, Antimicrobial Agents and Chemotherapy.

Use of Ancillary Carbapenemase Tests To Improve Specificity of Phenotypic Definitions for Carbapenemase-Producing Enterobacteriaceae

R. Humphries, J. Hindler, Shelley A. Miller, 2017, Journal of Clinical Microbiology.